Intermittent androgen suppression in prostate cancer: an update of the Vancouver experience.
about
Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.
P2860
Intermittent androgen suppression in prostate cancer: an update of the Vancouver experience.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intermittent androgen suppress ...... e of the Vancouver experience.
@ast
Intermittent androgen suppress ...... e of the Vancouver experience.
@en
type
label
Intermittent androgen suppress ...... e of the Vancouver experience.
@ast
Intermittent androgen suppress ...... e of the Vancouver experience.
@en
prefLabel
Intermittent androgen suppress ...... e of the Vancouver experience.
@ast
Intermittent androgen suppress ...... e of the Vancouver experience.
@en
P2093
P1476
Intermittent androgen suppress ...... e of the Vancouver experience.
@en
P2093
Kapil Bhagirath
Martin Gleave
Michael Pether
S Larry Goldenberg
P304
P577
2003-04-01T00:00:00Z